FDA Inspection 1009901 — New York Blood Center, Inc.
The FDA completed an inspection of New York Blood Center, Inc. on Apr 25, 2017 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 25, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Brunswick, NJ (United States)